Aesculap: From Products to Process
Executive SummaryLike its parent company, B. Braun, Aesculap has built a business around a broad-based offering of products, in this case general and specialty surgical instruments and devices and orthopedic implants. Such a strategy enables Aesculap to leverage everything from product development to sales and marketing. But now, as Aesculap seeks to extend such leveraging to collaborations with its parent company, the company walks a fine line between exploiting natural synergies without sacrificing the focus that made it successful in the first place.
You may also be interested in...
Company says it has learnt from gene therapy flop Glybera, and claims best-in-class status for viral vector.
Softening provisions to make EU-wide joint clinical assessments voluntary would make proposed legislation on HTA cooperation redundant, says Eurordis.